Listen to the voice of the market and convey corporate value - offline institutions conduct field research on Dayang Biotech ###
On the morning of June 24, 2021, the "Into the Excellent Listed Companies" offline institutional research guest group jointly organized by Flush, Northeast Securities and Xiangshu Assets visited the company on the spot, and Mr. Chen Yanggui, chairman and general manager of the company, Mr. Wang Xianyu, vice chairman and deputy general manager, Mr. Qiu Yongsheng, director and deputy general manager, Ms. Chen Xujun, financial director, Mr. Xu Xuping, secretary of the board of directors, and other senior executives of the company received warmly.
At the beginning of the event, under the leadership of Mr. Wang Guoping, director of the R&D Center, the research guest group visited the R&D quality inspection center and the historical and cultural exhibition hall to further understand the company's development history and product technology honors. Subsequently, the research team went to visit the company's factory area, and through the detailed explanation of various production equipment and hazardous waste treatment programs by Mr. Wang Xianyu, vice chairman and deputy general manager, fully understood the company's advanced chemical production technology and environmental protection innovation ability.
After the visit, the senior leaders also arranged a seminar for the exchange of research groups. Mr. Xu Xuping, Secretary of the Board of Directors, introduced to the guests in detail the development of enterprises from the establishment of chemical plants to the establishment of group companies, capital operations from the new third board listing to the successful listing on the Shenzhen Stock Exchange through on-site sharing; listed and explained the main product applications and industry conditions of potassium carbonate, potassium bicarbonate, veterinary drugs aminoamine hydrochloride, and fluorine-containing fine chemicals, of which potassium carbonate and potassium bicarbonate production capacity technology occupies an absolute leading position in the world; and for the technical advantages of the main products, the 2020 annual report and the first quarterly report of 2021, Detailed interpretation and analysis of future growth space and other contents have been carried out.
Mr. Chen Yanggui, Chairman and General Manager of the Company, stressed that Dayang Bio will adhere to the business philosophy of "green development, quality first, contract spirit, and win-win co-creation", take market demand as the guide, safety and environmental protection as the cornerstone, technological innovation as the driving force, based on existing advantageous products, strengthen new product development, and form an industrial pattern of "one body and two wings" for the common development of potash salt, veterinary drugs and fluorine chemicals.
In the subsequent interactive exchange session, in a simple and relaxed environment, the company's executives and institutional guests fully exchanged views on the company's operation and production, technology research and development, project construction, investment and customs management, industry competitors and the group's future development planning.
Through this research and exchange, the company's development strategy, operating conditions, development concept and core values have been fully demonstrated, and the in-depth interaction and discussion between listed companies and investors in the capital market have been realized.